Related case:
ADAPI 2023_08 Amandeep vs INADA
October 20, 2023
In August 2022 the India National Anti-Doping Agency (INADA) reported an anti-doping rule violation against the Athlete Amandeep after his sample tested positive for the prohibited substance Darbepoetin (dEPO).
Following notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).
The Athlete accepted the test result and denied the intentional use of the substance. He stated that he had received dEPO injections on advice of his coach as treatment for his pain and discomfort.
The Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation.
The Panel deems that the Athlete acted intentionally in his conduct through his use of injections of an unknown substance and without any consultation of a doctor.
Therefore the ADDPI Panel decides on 3 February 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 26 August 2022.
